




Selpercatinib, also known as Retevmo, is a targeted therapy drug used to treat advanced non-small cell lung cancer (NSCLC) and medullary thyroid cancer with RET gene fusions. While it demonstrates significant efficacy in treating these cancers, it can also cause various adverse reactions. Understanding these side effects is crucial for patients to manage their treatment effectively.
Selpercatinib's common adverse reactions include hypertension, diarrhea, nausea, vomiting, fatigue, muscle pain, and edema. These side effects are generally manageable with appropriate medical guidance and lifestyle adjustments. However, some rare but severe reactions may require immediate medical attention.
Hypertension: Selpercatinib can elevate blood pressure, necessitating regular monitoring. If blood pressure becomes uncontrolled, the dosage may need adjustment or the drug may be temporarily discontinued.
Diarrhea: Diarrhea is a frequent side effect that can lead to dehydration. Patients should stay hydrated and consult their doctor if symptoms persist or worsen.
Nausea and Vomiting: These symptoms can affect appetite and quality of life. Anti-nausea medications may be prescribed to alleviate these side effects.
Heart Arrhythmias: Selpercatinib may cause heart rhythm disturbances, such as tachycardia or bradycardia. Immediate medical attention is necessary if these symptoms occur.
Liver Function Abnormalities: The drug can lead to elevated liver enzymes and jaundice. Regular liver function tests are essential, and the drug may need to be stopped if liver function significantly declines.
Bleeding: Selpercatinib can increase the risk of bleeding, including gastrointestinal and nasal bleeding. Any unexplained bleeding should prompt an immediate visit to the doctor.
Interstitial Lung Disease (ILD)/Pneumonia: Patients should be monitored for respiratory symptoms such as shortness of breath, cough, and fever. The drug may need to be paused or discontinued if ILD is confirmed.
QT Interval Prolongation: This condition can lead to serious heart rhythm problems. Monitoring of QT interval, electrolytes, and thyroid-stimulating hormone (TSH) is recommended, especially when using other drugs that prolong the QT interval.
In conclusion, while Selpercatinib offers significant benefits in treating specific cancers, patients should be aware of the potential side effects and work closely with their healthcare providers to manage them effectively.
To ensure the safe and effective use of Selpercatinib, patients should follow specific guidelines and take necessary precautions. Here are some key points to consider:
Medical History: Inform your doctor about any pre-existing conditions, such as heart disease, high blood pressure, or liver problems. This information is crucial for tailoring the treatment plan.
Medication Review: Provide a complete list of all medications you are taking, including over-the-counter drugs and supplements. Some medications can interact with Selpercatinib and affect its effectiveness or increase the risk of side effects.
Regular Check-ups: Attend all scheduled appointments with your healthcare provider. Regular monitoring of blood pressure, liver function, and heart rhythm is essential to detect and manage side effects early.
Laboratory Tests: Your doctor will order periodic blood tests to check for changes in liver enzymes, electrolyte levels, and other important indicators. Follow these test schedules diligently.
Diet and Hydration: Maintain a balanced diet and stay well-hydrated, especially if you experience diarrhea. Avoid foods that exacerbate digestive issues.
Physical Activity: Engage in light to moderate physical activity as tolerated. Exercise can help manage fatigue and improve overall well-being, but avoid overexertion.
By following these guidelines and working closely with your healthcare team, you can maximize the benefits of Selpercatinib while minimizing the risk of adverse reactions. Regular communication with your doctor is key to ensuring a safe and effective treatment journey.
免费咨询电话
400-001-2811